~~<i id='CA8E6640E2'><strike id='CA8E6640E2'><tt id='CA8E6640E2'><pre id='CA8E6640E2'></pre></tt></strike></i>~~

Home» knowledge» hotspot

hotspot

author：comprehensive 2025-09-06 08:01:58 Page View：5353

HHS 2020 — PhRMA is suing the Biden administration over its new Medicare drug price negotiation program. Graeme Sloan/Sipa USA

WASHINGTON — After losing the drug pricing fight on Capitol Hill, PhRMA is taking its battle to the courts.

The pharmaceutical industry’s biggest lobbying group on Wednesday filed a long-expected lawsuit challenging Democrats’ drug pricing law that allowed Medicare to start negotiating prices for certain medicines.

PhRMA joins a growing club of companies and trades challenging the law. Merck, Bristol Myers Squibb, and the Chamber of Commerce have already filed similar suits in different courts.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： A look at other Americans who have crossed into North Korea over the years
Next article： United colonoscopy coverage change 'may cost lives,' doctors say

explore

Tori Bowie and the unacceptable rates of Black maternal death

AlastairGrant/APThehorrorstoriesofBlackwomendyingorcomingclosetodeathinchildbirthneverseemtostopcomi

STAT Health News: Apple Watch import ban, Pfizer fumbles, etc

Understandhowscience,healthpolicy,andmedicineshapetheworldeveryday.SignupforourMorningRoundsnewslett

How to save PrEP access — and even expand it

UndertheAffordableCareAct,healthinsurersarerequiredtocoverallcostsassociatedwithpreventivecare—inclu

Three trends to watch in biotech in 2024

ChristineKao/STATEverywinter,likePunxsutawneynobles,biotech’smanythoughtleadersgatherfortheJ.P.Morga